The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Recursion Pharmaceuticals Inc’s current trading price is -44.92% away from its 52-week high, while its distance from the 52-week low is 21.57%. The stock’s price range for this period has been between $5.60 and $12.36 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.12 million for the day, a number notably lower than the average daily volume of 23.28 million over the last three months.
Recursion Pharmaceuticals Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $12.36 on 02/18/25, while the lowest price for the same duration was marked at $5.60 on 11/22/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly rise of 9.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.74B.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.15, with a change in price of +0.29. Similarly, Recursion Pharmaceuticals Inc recorded 18,749,461 in trading volume during the last 100 days, posting a change of +4.48%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
RXRX Stock Stochastic Average
As of today, Recursion Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 15.69%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 34.92%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 24.67% and 19.11%, respectively.
RXRX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 0.71% this year. Over the last six months, there has been a stronger performance of -1.90%. The price of RXRX leaped by -26.64% during the last 30 days period. For the last 5-days stocks have slided -0.47%.
